tions of the human SLC26A4/PDS gene constitute the most common cause of syndromic and nonsyndromic hearing loss. Definition of the SLC26A4 mutation spectrum among different populations with sensorineural hearing loss is important for development of optimal genetic screening services for congenital hearing impairment. We screened for SLC26A4 mutations among Chinese and U.S. subjects with hearing loss, using denaturing HPLC (DHPLC) and direct DNA sequencing. Fifty-two of 55 Chinese subjects with deafness accompanied by enlargement of the vestibular aqueduct (EVA) exhibited at least one mutant SLC26A4 allele, whereas SLC26A4 mutations were found in only 2 of 116 deaf Chinese patients without EVA. The spectrum of SLC26A4 mutations differed among Chinese and U.S. subjects and included 10 previously unreported
Definition of the SLC26A4 mutation spectrum among different populations with sensorineural hearing loss is important for development of optimal genetic screening services for congenital hearing impairment. We screened for SLC26A4 mutations among Chinese and U.S. subjects with hearing loss, using denaturing HPLC (DHPLC) and direct DNA sequencing. Fifty-two of 55 Chinese subjects with deafness accompanied by enlargement of the vestibular aqueduct (EVA) exhibited at least one mutant SLC26A4 allele, whereas SLC26A4 mutations were found in only 2 of 116 deaf Chinese patients without EVA. The spectrum of SLC26A4 mutations differed among Chinese and U.S. subjects and included 10 previously unreported SLC26A4 variants: 4 in the Chinese population (p.E303Q, p.X329, p.X467, p.X573) and 6 in the U.S. population (p.V250A, p.D266N, p.F354S, p.D697A, p.K715N, p.E737D). Among the seven novel inframe missense mutations, five encoded SLC26A4 proteins with substantially reduced Cl Ϫ /anion exchange activity as expressed and measured in Xenopus oocytes, but four of these were sufficiently active to allow study of anion selectivity. The only mutant polypeptide exhibiting complete loss of anion exchange function, p.E303Q, was expressed at or near the oocyte surface at near-wild-type levels. Two variants, p.F354S and p.E737D, displayed selective reduction in relative rate of Cl 
/Cl
Ϫ and Cl Ϫ /I Ϫ exchange. Our data show that mutation analysis of the SLC26A4 gene is of high diagnostic yield among subjects with deafness and bilateral EVA in both China and the U.S. However, the pathogenicity of monoallelic SLC26A4 gene variants in patients with hearing loss remains unclear in many instances. Pendred syndrome; chloride/bicarbonate exchange; iodide transport; enlargement of vestibular aqueduct; goiter MUTATIONS IN SLC26A4 cause Pendred syndrome (PS) and nonsyndromic deafness (DFNB4) (9, 16) . Among nearly 200 previously described SLC26A4 mutations (www.healthcare.uiowa. edu/labs/pendredandbor/slcMutations.htm and unpublished data), most have been identified in western populations with European ancestry, and most are private mutations (2, 4, 5, 9, 11-14, 16, 17, 19, 20, 30 -33, 36, 38) . PS (OMIM 274600) indicates sensorineural hearing loss (SNHL) with thyroid dysfunction, while DFNB4 (OMIM 600791) indicates nonsyndromic SNHL (NS-SNHL) with normal thyroid function. Both conditions are autosomal recessive. Together they account for 4 -10% of all hereditary deafness (18) and are frequently associated with temporal bone abnormalities (TBA) detectable by high-resolution imaging (25, 35) .
Bilateral enlargement of the vestibular aqueducts (EVA) is the most frequent form of TBA (31) and is observed in ϳ16% of subjects with idiopathic SNHL (23) . EVA in several Asian populations is associated with a characteristic SLC26A4 mutation spectrum including highly prevalent founder mutations such as p.H723R in Japan and Korea and c.919-2AϾG (often referred to as IVS7-2AϾG) in Taiwan and mainland China (6, 7, 19, 20, 30, 31, 33, 36) . Thus knowledge about ethnic and population differences in SLC26A4 mutation prevalence can help guide genetic testing in assisting clinical decision-making.
Only a minority of the many SLC26A4 mutations have undergone functional testing (4, 21, 27, 38) . Homozygous and compound heterozygous mutations from patients with PS or with NS-SNHL have exhibited abnormal cell surface targeting and/or defective function. However, among monoallelic pendrin mutations found in NS-SNHL patients, a substantial proportion have exhibited no apparent loss of function. In this setting, attribution of deafness to SLC26A4 mutation remains problematic (4) .
In the present paper we describe the spectrum of SLC26A4 mutations in Chinese and U.S. patients with hearing loss, with and without TBA. We report 10 novel missense mutations of SLC26A4 and subject all nontruncating missense mutations to functional analysis in Xenopus oocytes. One novel mutation encodes a protein that is nonfunctional despite normal abundance at or near the oocyte surface. Two of the novel mutations exhibit altered anion selectivity. The reported missense vari-ants extend the range of known pendrin mutations among Chinese and U.S. deaf populations and reinforce the growing body of data showing that pendrin mutations in some patients do not suffice to explain the pathology of SNHL.
MATERIALS AND METHODS
Chinese subjects. Blood samples were submitted by a single team of specialists in otolaryngology and audiology for clinical molecular diagnostic testing. We screened 55 Han Chinese probands with NS-SNHL and bilateral EVA from 50 unrelated families, 10 multiplex and 45 simplex families (Table 1) . EVA was defined by computerized tomography (CT) scan as a diameter Ն1.5 mm measured midway between the operculum and the common crus. The type and severity of SNHL were confirmed by formal audiological testing. Family history, clinical information, and informed consent were collected from all families.
One hundred sixteen clinical samples from unrelated deaf Han Chinese children without TBA were also studied under the same protocol. In addition, 131 unrelated deaf children with severe-toprofound bilateral SNHL were screened for the most common Han Chinese mutation, c.919-2AϾG (IVS7-2AϾG), before CT evaluation. Samples from affected and at-risk family members (nominally obligate or possible carriers) were obtained after genetic counseling and evaluated for the presence of the proband's mutation. Anonymous DNA samples from 100 Han Chinese individuals without known hearing loss or other genetic disorders were analyzed as control subjects. All protocols were approved by the PLA General Hospital Institutional Review Board.
U.S. subjects. We screened three sets of anonymized DNA samples from discarded clinical samples obtained from unrelated U.S. subjects (Table 2 ) with 1) NS-SNHL with documented TBA (n ϭ 50); 2) NS-SNHL with unknown TBA status (n ϭ 205); and 3) control subjects with no known hearing loss or genetic disorder (n ϭ 100); 69.5% of these subjects were Caucasian, 13% were African American, and 3% were of Asian origin. The ethnicity of 14.5% of these anonymized subjects could not be ascertained. All protocols were approved by the Children's Hospital Boston Institutional Review Board.
SLC26A4 mutation scanning and sequencing. DNA was prepared from whole blood with a D-50K PureGene DNA isolation kit (Gentra, Minneapolis, MN). Testing for all Chinese and U.S. samples was performed in their respective hospitals' diagnostic laboratories according to standard protocols for PCR amplification, denaturing HPLC (DHPLC) screening of all exons, and direct sequencing (see Supplemental Table S1 for PCR primer sequences for DHPLC and DNA sequencing).
1 PCR products with altered DHPLC patterns (see Supplemental Table S2 for mutation scanning parameters) were purified (Wizard PCR Prep DNA Purification System, Promega, Minneapolis, MN) for follow-up bidirectional sequencing to confirm the mutations. Sequencing reactions (12 l; BigDye Terminator Cycle Sequencing Ready Reaction Kit) contained 50 ng of the purified PCR product and 10 pmol of each pair of sequencing primers run on ABI PRISM sequencers (Applied Biosystems, Foster City, CA). Sequencher 4.1 software (GeneCode, Baltimore, MD) was used for 1 The online version of this article contains supplemental material. NS-SNHL, nonsyndromic sensorineural hearing loss; TBA, temporal bone abnormality; SS, splice site; WT, wild type; HL, hearing loss. Mutations in bold are previously unreported. All subjects in group A had bilateral enlarged vestibular aqueduct (EVA). All subjects in group D (severe to profound SNHL) had c.919-2AϾG and p.H723R screening before computerized tomography (CT) imaging. Note: Genotyping of subjects in groups A and B and control group C was performed by both denaturing HPLC (DHPLC) scan and direct sequencing; subjects in group D were scanned by DHPLC and direct sequencing for c.919-2AϾG and p.H723R only. mutation analysis (see Supplemental Fig. S1 for example). The SLC26A4 reference sequence used for all analyses was NCBI accession number NM_000441. A series of 12 anonymous proficiency testing samples (10 abnormal, 2 normal) was tested in both laboratories, with 100% concordance.
cRNA expression in Xenopus oocytes. Full-length human SLC26A4 cDNA carrying a 6-His tag at its COOH terminus was subcloned into pGEM-HE (gift of B. Choi and A. Griffith, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, MD). SLC26A4 mutant cDNAs were prepared by the four-primer PCR method as previously described (3), with the PCR primers summarized in Supplemental Table S3 . All PCR-amplified cDNA was sequenced on both strands to ensure the absence of unintended introduced mutations. Capped SLC26A4 cRNA was transcribed from Sph1-linearized pGEM-HE cDNA templates with the T7 MEGAscript kit (Ambion, Austin, TX) and resuspended in diethylpyrocarbonate-treated water. RNA integrity was confirmed by agarose gel electrophoresis in formaldehyde, and RNA concentration was estimated by absorbance at 260 nm (A 260) (Nanodrop, Wilmington, DE).
Ovarian segments were excised from female Xenopus laevis (colony of the Department of Systems Biology, Harvard Medical School) anesthetized with 0.17% tricaine according to protocols approved by the Institutional Animal Care and Use Committee of Beth Israel Deaconess Medical Center. Stage V-VI oocytes from ovarian fragments were incubated overnight at 19°C with 1.3 mg/ml collagenase type A (Boehringer Mannheim) in ND-96 (see below) supplemented with 50 ng/ml gentamicin. Individual oocytes were injected 24 h after harvest with 50 nl of cRNA solution containing 1-50 ng cRNA (as indicated) or with 50 nl of H 2O. Injected oocytes were maintained for 2-4 days at 19°C in ND-96 (see below) with added gentamicin. 36 Cl Ϫ efflux measurements. ND-96 consisted of (in mM) 96 NaCl, 2 KCl, 1.8 CaCl2, 1 MgCl2, 5 HEPES, and 2.5 sodium pyruvate, pH 7.40. Flux medium lacked sodium pyruvate. In Cl Ϫ -free solutions, NaCl was replaced isosmotically with sodium isethionate, and equimolar K, Ca, and Mg gluconate substituted for the corresponding Cl Ϫ salts. CO2/HCO 3 Ϫ -buffered solutions of pH 7.4 were saturated with 5% CO2-95% air at room temperature for ϳ1 h and differed from Cl Ϫ -free ND-96 in replacement of 24 mM sodium isethionate with 24 mM NaHCO3. pH of CO2/HCO 3 Ϫ -buffered solutions was verified before each experiment. Salts were from Sigma. Na 36 Cl was from GE HealthCare (Piscataway, NJ). 36 Cl Ϫ efflux assays were performed at room temperature as previously described (4, 28) . Oocytes were injected with 50 nl of 130 mM Na 36 Cl (10,000 -12,000 cpm) while in Cl Ϫ -free ND-96. After a 10-min recovery period in Cl Ϫ -free ND-96, the efflux assay was initiated by transfer of individual oocytes to 6-ml borosilicate glass tubes containing 1 ml ND-96 efflux solution. At intervals of 3 min, 0.95 ml of this efflux solution was removed for scintillation counting and replaced with an equal volume of fresh efflux solution. After completion of the assay with a final efflux period in the presence of Cl Ϫ -free ND-96, each oocyte was lysed in 100 l of 2% sodium dodecyl sulfate (SDS). Samples were counted for 2 min such that the magnitude of 2SD was Յ5% of the sample mean. Cl Ϫ /HCO 3 Ϫ exchange was measured as 36 Cl Ϫ efflux into a solution containing 24 mM NaHCO3 and 72 mM sodium isethionate, previously equilibrated with 5% CO2-95% air for 1 h at room temperature. Cl Ϫ /I Ϫ exchange was measured as 36 Cl Ϫ efflux into a solution containing 5 mM sodium Mutations in bold are previously unreported. All subjects had TBA: the majority had EVA, and the remainder had other types of TBA.
iodide and 96 mM sodium isethionate. HCO 3 Ϫ solutions and iodide solutions each contained gluconate salts of K ϩ , Mg 2ϩ , and Ca 2ϩ . Experimental data were plotted as ln(% cpm remaining in the oocyte) vs. time. 36 Cl Ϫ efflux rate constants were measured from linear fits to data from the last three time points sampled for each experimental condition. Within each set of experiments, water-injected and pendrin cRNA-injected oocytes from the same frog were subjected to parallel measurements. On each experimental day, activity of tested mutant pendrin polypeptides was compared with wildtype (wt) pendrin activity at pH 7.4. To assess possible changes in pendrin anion selectivity, 36 Confocal immunofluorescence microscopy. Oocytes (10 -12/group) were injected with water or cRNA in the amounts indicated in Fig. 1 . Forty-eight to seventy-two hours later they were fixed for 30 min in 3% paraformaldehyde in phosphate-buffered saline (PBS) at room temperature, quenched in PBS containing 50 mM glycine for 30 min, and washed three times in PBS containing 0.002% sodium azide. All subsequent steps were at 4°C. The fixed oocytes were blocked in PBS with 1% bovine serum albumin and 0.05% saponin (PBS-BSA) for 1 h and then incubated 1 h with mouse monoclonal anti-6-His antibody (Sigma; dilution 1:1,200), followed by 3 ϫ 10-min washes. Oocytes were then incubated 1 h with Cy3-conjugated secondary donkey anti-rabbit Ig (Jackson Immunochemicals; dilution 1:200) and again thoroughly washed in PBS-BSA.
Antibody-reacted oocytes were aligned in uniform orientation along a Plexiglas groove and sequentially imaged through the ϫ10 objective of a Zeiss LSM510 laser scanning confocal microscope using the 543-nm laser line at 512 ϫ 512 resolution at a uniform setting of 80% intensity, pinhole 188 (2.2 Airy units), detector gain 785, Amp gain 1, zero amp offset. Image acquisition was at uniform settings, and images processed in Image J v. 1.38 (NIH) were compiled in MS Powerpoint.
His-tagged pendrin polypeptide abundance at or near each oocyte surface was estimated by quantitation (Image J v. 1.38) of specific fluorescence intensity (FI) at the circumference of one quadrant of an equatorial focal plane (Fig. 2J) . Mean background-corrected FI for quadrants of oocytes previously injected with water was subtracted from the background-corrected FI for quadrants of individual cRNAinjected oocytes to yield intensity values for surface-associated specific FI for each oocyte. Specific FIs of oocytes expressing wt and mutant His-tagged pendrin polypeptides were compared with Dunnett's two-tailed t-test. P Ͻ 0.05 was interpreted as significant.
RESULTS

SLC26A4 mutation analysis of Chinese samples.
Fifty-two of fifty-five children (95%) with NS-SNHL and bilateral EVA had at least one mutant SLC26A4 allele, for a detection rate of 93% in sporadic cases (42 of 45 families) and 100% in familial cases (5 families with 10 deaf children; Table 1A ). Among these families, 36 cases (76%) had two disease-causing mutations (42% homozygotes; 24% compound heterozygotes), 16 cases had a single mutation, and 3 families had no detectable mutation (Table 1A ). All affected family members (deaf siblings) and at-risk family members (obligate or possible carriers) were studied. All the deaf siblings had the same mutation as the proband. All parents of deaf children with biallelic mutations (homozygotes or compound heterozygotes) were obligate carriers of the familial mutations. DNA sequence data for the homozygous mutation p.T410M in such a Chinese family (deaf child and nonconsanguineous parents who are both obligate carriers) is presented in Supplemental Fig. S1 .
In contrast, we detected only two cases with heterozygous c.919-2AϾG among the 116 cases of NS-SNHL without TBA (Table 1B) . Among the 100 control samples (Table 1C) , we found a single carrier of c.919-2AϾG. We identified a c.919-2AϾG mutation before CT imaging in 27 of 131 subjects (20.6%) with bilateral severe-to-profound SNHL (Table 1D) . Of those, all homozygotes and 80% of heterozygotes had EVA confirmed by follow-up CT imaging. Additional screening for p.H723R in this group revealed a prevalence of 3.8% for this mutation (5/131).
Among ethnic Chinese, four novel mutations and five previously described mutations were identified (Table 1A) . 36 Cl Ϫ efflux mediated by wild-type (wt) and mutant pendrin (PDS) polypeptides expressed in Xenopus oocytes. A: 36 Cl Ϫ efflux from oocytes (nos. in parentheses) previously injected with indicated amounts of cRNA encoding pendrin variants, either 1 ng or the indicated quantity chosen to approximate or exceed the rate constant exhibited by oocytes injected with 1 ng of cRNA encoding wt pendrin. Asterisks preceding D697A, K715N, and E737D correspond to 1 ng of injected cRNA. B: functional consequences of the COOHterminal HA epitope tag were tested by evaluating 36 Cl Ϫ efflux from oocytes previously injected with 1 ng of cRNA encoding the untagged or HA-tagged wt pendrin polypeptides. Oocytes expressing untagged pendrin mutant p.E303Q were injected with 1 ng or with 20 ng of cRNA, and the similar results were pooled for presentation. Additional oocytes were injected with cRNA encoding HA-tagged pendrin mutant p.E303Q. The pooled results are from oocytes injected with cRNA quantities of 10 -50 ng.
Among the novel mutations, c.916insG (p.X329), c.1199insT (p.X467), and c.1693insA (p.X573) encode either frame shift or nonsense mutations resulting in early translational termination, severe truncation of the 780 residue wt pendrin polypeptide, and, very likely, nonfunctional and/or unstable polypeptide products. The fourth novel mutation is the missense mutation E303Q, found as a compound heterozygote with the previously described H723R mutation (19, 27) . The previously described mutations c.919-2AϾG (73% prevalence) and p.H723R (14% prevalence) together accounted for 87% of Chinese subjects with NS-SNHL and EVA.
SLC26A4 mutation analysis in U.S. samples. In the U.S. group, SLC26A4 mutations were identified in only 10 of 50 subjects (20%) with NS-SNHL and TBA (Table 2A ) and 22 of 205 subjects (10.7%) with NS-SNHL of unknown TBA status (Table 2B ). All mutations were found in patients heterozygous for the wt SLC26A4 allele and included six previously unreported variants. Among these novel missense mutations, p.F354S was present in three unrelated deaf subjects and p.E737D was found in two unrelated deaf subjects. The remaining variants (p.V250A, p.D266N, p.D697A, and p.K715N) each were observed in single patients. The previously reported missense mutations p.F335L, p.I713M, and p.L597S were found in five, four, and three unrelated families, respectively. No mutation was detected among the 100 control samples (Table 2C) . 
Cl
Ϫ
/Cl
Ϫ exchange activity of novel mutant pendrin polypeptides. We assessed the consequences to anion transport function of all novel Slc26a4 missense mutations. To facilitate assessment of surface trafficking, wt pendrin and pendrin mutants carried a COOH-terminal 6-His epitope tag. COOHterminal epitope tag modification of pendrin has previously been shown not to modify surface trafficking in Madin-Darby canine kidney (MDCK) (10) and COS-7 cells (4). Initial screening of Cl Ϫ transport activity was designed to select injected cRNA amounts for each mutant that would approximate wt pendrin activity, to facilitate subsequent functional comparison. As shown in Fig. 1A , 36 Cl Ϫ efflux activity of oocytes expressing mutants p.V250A, p.D266N, and p.F354S was indistinguishable from that of wt pendrin. Larger amounts of cRNA (5-20 ng) were used for functional tests of pendrin mutants p.D697A, p.K715N, and p.E737D, because these mutant polypeptides exhibited little or no function after injection of only 1 ng of cRNA. Mutant p.E303Q was nonfunctional even after injection of 50 ng cRNA (Fig. 1A) .
Removal of the COOH-terminal 6-His epitope tag did not alter the function of wt pendrin and did not rescue function of loss-of-function mutant p.E303Q (Fig. 1B) . These data suggest that the presence of the epitope tag did not modify function of the mutant pendrin polypeptides.
Oocyte surface expression of novel mutant pendrin polypeptides. The reduction or loss of anion transport function displayed by some of the novel pendrin mutants could arise from an intrinsic defect in anion translocation or from reduced polypeptide abundance at the oocyte surface. We assessed wt and mutant pendrin polypeptide expression at or near the oocyte surface by confocal immunofluorescence microscopy. As shown in Fig. 2 , A-C, nonfunctional pendrin mutant p.E303Q (expressed from 50 ng cRNA) accumulated at or near the oocyte surface at levels equivalent to those of wt pendrin (expressed from 1 ng cRNA). In contrast, the mutants p.D697A, p.K715N, and p.E737D, which expressed little or no transport function in oocytes injected with 1 ng of cRNA but functioned well in oocytes injected with higher amounts of cRNA, each exhibited cRNA dose-dependent expression at or near the oocyte surface (Fig. 2, D-I) . The results are summarized in Fig. 2J . Thus the complete loss-of-function phenotype of p.E303Q likely includes an intrinsic defect in the anion translocation mechanism. In contrast, the mutants with intermediate loss-of-function phenotypes are more likely reduced in trafficking efficiency to the oocyte surface, in some cases with defects that can be overcome by injection of higher cRNA amounts.
Anion selectivity of novel mutant pendrin polypeptides:
Pendrin is a multianion transporter, and pendrin mutations are associated with phenotypic variability. In the inner ear and in renal type B intercalated cells, pendrin mediates Cl Ϫ /HCO 3 Ϫ exchange. In the thyrocyte apical mem- Fig. 2A ) as a % of the rate constant for Cl Ϫ /Cl Ϫ exchange (measured in the same oocyte during the first time period of Fig. 2A) , as derived from the mean values in Fig. 2B . Values for nos. of oocytes indicated in parentheses (means Ϯ SE) expressing pendrin mutants p.F354S and p.E737D were lower than those of wt pendrin, as calculated by Dunnett's t-test for multiple group comparisons. Dashed line represents the value of the mean ratio for wt pendrin. *P Յ 0.05 compared with wt pendrin. The ratio could not be calculated for the nonfunctional mutant E303Q.
brane pendrin likely mediates Cl Ϫ /I Ϫ exchange. Demonstration of impaired efficiency of surface accumulation among some of the novel mutant pendrin polypeptides suggested altered protein folding or interactions that could also result in altered selectivity of anion exchange. We therefore compared Cl Ϫ / HCO 3 Ϫ exchange for each functional mutant pendrin polypeptide to that of wt pendrin. Individual oocytes were sequentially exposed to solutions in which they mediated Cl Ϫ /Cl Ϫ exchange and then Cl Ϫ /HCO 3 Ϫ exchange (Fig. 3, A and B) . Oocyte integrity was confirmed at the end of the experiment by exposure to bath lacking permeant anions. Cl Ϫ /HCO 3 Ϫ exchange activity was expressed as a ratio, normalized to Cl Ϫ / Cl Ϫ exchange activity in the same oocyte. Two mutants, p.F354S and p.E737D, exhibited reductions in normalized Cl Ϫ /HCO 3 Ϫ exchange activity (Fig. 3C) . Whereas p.F354S mediated wild-type rates of Cl Ϫ /Cl Ϫ exchange (Fig. 1A) , p.E737D was hypofunctional in Cl Ϫ /Cl Ϫ exchange. The other novel mutants for which activity could be measured had unchanged Cl Ϫ /HCO 3 Ϫ exchange rates relative to Cl Ϫ /Cl Ϫ exchange in the same oocytes (Fig. 3C) . 
Anion selectivity of novel mutant pendrin polypeptides: Cl
DISCUSSION
We have screened deaf children and their families among groups of Chinese and U.S. patients. We found an SLC26A4 mutation spectrum among Chinese subjects generally similar to those reported previously among patients from Taiwan, Korea, and Japan (19, 27, 30, 32, 33, 36) but distinct from that in U.S. subjects. Two highly prevalent mutations (c.919-2AϾG and p.H723R) account for a substantial portion of DFNB4 in East Asian populations. The SLC26A4 mutation c.919-2AϾG is common among Han Chinese and Koreans (6, 7, 11, 17, 20, 30, 32) but is rare among the ethnic groups of southwest and western China as well as among populations with European ancestry, including deaf subjects living in the U.S. (1, 2, 4, 11, 17, 33) . p.H723R is common among Japanese, Korean, and mainland Chinese populations but is rare in Taiwan. Table 3 summarizes the allele frequencies of these two prevalent SLC26A4 mutations detected in deaf patients with EVA from East Asian populations.
This study confirms and extends the spectrum of SLC26A4 alleles in children with SNHL living in the U.S. Although the 10 most frequently detected mutations in western populations (p.L236P, p.T416P, IVS8ϩ1GϾA, p.E384G, p.L445W, p.T410M, p.G209V, p.V138F, p.Y530H, p.L597S) account for close to 50% of all SLC26A4 disease-causing mutations in western populations by reports (1, 2, 5, 9, 11, 16, 17, 20, 22, 24, 30, 32) including this study, we did not detect IVS8ϩ1GϾA and p.L445W in our limited sample of U.S. subjects (255 cases). Furthermore, 9 of these 10 common mutations found in Western populations were not detected among Chinese subjects (302 cases). Only p.T410M was found among Fig. 3A) as % of the rate constant for Cl Ϫ /Cl Ϫ exchange (measured in the same oocyte during the first time period of Fig. 3A) , as derived from the mean values in Fig. 3B . Dashed line represents the value of the mean ratio for wt pendrin. Values (means Ϯ SE) for groups of oocytes (nos. in parentheses) did not differ from wt by Dunnett's t-test for multiple group comparisons. The ratio could not be calculated for the nonfunctional mutant p.E303Q.
Chinese subjects (Table 1) as a single homozygote and confirmed by a parental study (Supplemental Fig. S1 ). Mutation p.T410M has been previously detected as compound heterozygotes in Chinese and Korean populations (24, 31, 32) , suggesting either admixture or independent events in different populations.
Among subjects with both SNHL and TBA, the SLC26A4 mutation detection rate among U.S. subjects was dramatically lower than among ethnic Chinese (20% vs. 95%). The increased frequency of mutation detection among Chinese subjects likely reflects ascertainment bias, since a smaller proportion of U.S. subjects had bilateral EVA. Among Chinese SNHL subjects of unknown TBA status, SLC26A4 mutation frequency was only 20.6%, compatible with our previously reported frequency of 16% among 135 SNHL subjects from one region of north China (32). Our present study was not designed to differentiate PS and syndromic EVA from DFNB4/ nonsyndromic EVA. Recent studies (4, 24) have demonstrated that PS and DFNB4 are clinically and genetically distinct entities, and that the latter disease may be oligogenic, rather than monogenic as in nearly all cases of PS.
Our present study identified 10 previously unreported SLC26A4 mutations, 4 in Chinese subjects and 6 in U.S. subjects. The majority of novel mutations identified in Chinese subjects were frame shift or stop codon mutations confidently predicted to be pathogenic. All novel missense mutations found in U.S. subjects were variants of amino acid residues conserved in rat and mouse pendrin, and all mutations were absent from Chinese and U.S. control subjects. Among those pendrin residues in which novel mutations resulted in no apparent change in anion transport function, D266 is not conserved in any SLC26 paralog and V250 is conserved only in SLC26A2. p.F354S exhibited moderate, but selective, relative reduction in Cl Ϫ /HCO 3 Ϫ exchange activity, and F354 is identical in five of nine SLC26 paralogs and conservatively substituted in three others. The pendrin residues in which mutations were associated with reduced efficiency of trafficking to the oocyte's apparent surface are all located within or beyond the COOH-terminal cytoplasmic STAS domain. K715 is identical in the corresponding residues of four paralogs but unconserved in the others. D697 is conserved only in SLC26A3, but E737 is not conserved in any SLC26 paralog. Nonetheless, E737D resembles the more highly conserved F354S in its moderate but selective, relative reduction of Cl E303Q is a novel SLC26A4 mutation with thus far unique properties. The Chinese patient with E303Q (Table 1) is a compound heterozygote with H723R, the most commonly found missense mutation in East Asians. The lack of anion exchange detected in p.H723R-transfected cells is secondary to intracellular retention, and partial rescue of surface expression by chemical chaperonins proportionately rescues Cl Ϫ /HCO 3 Ϫ exchange. (38) . E303Q is also a complete loss-of-function mutation, even when measured in oocytes injected with 50 ng cRNA (Fig. 1) , a condition in which nominal surface expression of the mutant is at the wild-type level (Fig. 2) . This complete loss-of-function phenotype in the setting of apparently normal surface expression suggests an important role for E303Q in the anion exchange mechanism of pendrin. The conservation of this Glu residue in the corresponding positions of nine paralogous human SLC26 polypeptides, and the conservative change to Asp in the corresponding position of the tenth, SLC26A7, additionally suggest the importance of this side chain negative charge throughout the SLC26 superfamily. Further investigation of E303 and adjacent pendrin residues should contribute to increased understanding of anion exchange mechanisms common to all SLC26 transporters. Since SLC26A9 (8, 37) and A7 (15) also function as Cl Ϫ channels (Vandorpe, Stewart, and Alper, unpublished data), examination of a possible contribution of the corresponding Glu residues to the anion conductance mediated by these polypeptides will also be worthwhile.
SLC26A4 mutations are a common cause of hearing loss related to PS or DFNB4 in both Chinese and U.S. populations, but the mutation spectrum varies in these two populations. Our data indicate a possibly increased yield for targeted mutation analysis among Chinese subjects with bilateral EVA. However, in the absence of high-resolution temporal bone imaging, molecular diagnosis still requires in mutation scanning or sequencing of the entire SLC26A4 gene in both populations. 
